North America Next Generation Sequencing (NGS) Market Insights and...

North America Next Generation Sequencing (NGS) Market Insights and Growth Trends 2024–2030

Posted 2025-03-03 17:30:23

The North America Next Generation Sequencing (NGS) Market sector is undergoing rapid transformation, with significant growth and innovations expected by 2030. In-depth market research offers a thorough analysis of market size, share, and emerging trends, providing essential insights into its expansion potential. The report explores market segmentation and definitions, emphasizing key components and growth drivers. Through the use of SWOT and PESTEL analyses, it evaluates the sector’s strengths, weaknesses, opportunities, and threats, while considering political, economic, social, technological, environmental, and legal influences. Expert evaluations of competitor strategies and recent developments shed light on geographical trends and forecast the market’s future direction, creating a solid framework for strategic planning and investment decisions.

Get a Sample PDF of Report - https://www.databridgemarketresearch.com/request-a-sample/?dbmr=north-america-next-generation-sequencing-ngs-market

Which are the top companies operating in the North America Next Generation Sequencing (NGS) Market?

The report profiles noticeable organizations working in the water purifier showcase and the triumphant methodologies received by them. It likewise reveals insights about the share held by each organization and their contribution to the market's extension. This North America Next Generation Sequencing (NGS) Market report provides the information of the Top Companies in North America Next Generation Sequencing (NGS) Market in the market their business strategy, financial situation etc.

Agilent Technologies, Inc. (U.S.), ThermoFisher Scientific, Inc. (U.S.), QIAGEN (Netherlands), llumina, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), BGI (A subsidiary of BGI Group) (China), Oxford Nanopore Technologies plc (U.K.), Illumina, Inc. (U.S.), Pacific Biosciences of California, Inc. (U.S.), 10x Genomics, Inc. (U.S.), PerkinElmer, Inc. (U.S.), Genewiz (U.S.), Partek Incorporated (U.S.), Becton, Dickinson and Company (BD) (U.S.), Genomic Health, Inc. (U.S.), Guardant Health, Inc. (U.S.), Personalis, Inc. (U.S.)

Report Scope and Market Segmentation

Which are the driving factors of the North America Next Generation Sequencing (NGS) Market?

The driving factors of the North America Next Generation Sequencing (NGS) Market are multifaceted and crucial for its growth and development. Technological advancements play a significant role by enhancing product efficiency, reducing costs, and introducing innovative features that cater to evolving consumer demands. Rising consumer interest and demand for keyword-related products and services further fuel market expansion. Favorable economic conditions, including increased disposable incomes, enable higher consumer spending, which benefits the market. Supportive regulatory environments, with policies that provide incentives and subsidies, also encourage growth, while globalization opens new opportunities by expanding market reach and international trade.

North America Next Generation Sequencing (NGS) Market - Competitive and Segmentation Analysis:

**Segments**

- On the basis of product & service, the North America Next Generation Sequencing (NGS) market can be segmented into pre-sequencing products & services, NGS platforms, consumables, services for platforms, sequencing services, data analysis storage & management, and others.
- Based on technology, the market can be categorized into sequencing by synthesis, ion semiconductor sequencing, sequencing by ligation, pyrosequencing, single-molecule real-time sequencing (SMRT), and other sequencing technologies.
- By application, the market can be divided into diagnostics, drug discovery, biomarker discovery, personalized medicine, agriculture & animal research, and other applications.
- On the basis of end-user, the NGS market can be segmented into academic research centers, pharmaceutical & biotechnology companies, hospitals & clinics, and other end-users.
- Lastly, based on region, the market is analyzed in North America as a whole.

**Market Players**

- Some of the key players in the North America Next Generation Sequencing (NGS) market include Illumina, Inc., Thermo Fisher Scientific Inc., Qiagen, Agilent Technologies, Inc., BGI, PerkinElmer Inc., F. Hoffmann-La Roche Ltd, Oxford Nanopore Technologies, Pacific Biosciences of California, Inc., 10x Genomics, Macrogen, Inc., Eurofins Scientific, Takara Bio Inc., and Bio Rad Laboratories, among others.

By 2030, the North America Next Generation Sequencing (NGS) market is projected to witness substantial growth due to factors such as advancements in sequencing technologies, increasing applications of NGS in various sectors like diagnostics and drug discovery, and growing investments in genomics research. The segment-wise analysis of the market provides insights into the diverse product & service offerings, technologies, applications, and end-users driving market growth. Companies involved in the market are focusing on strategic collaborations, product launches, and acquisitions to expand their market presence and gain aThe North America Next Generation Sequencing (NGS) market is poised for significant growth by 2030, driven by several key factors. Advancements in sequencing technologies are leading to improvements in the speed, accuracy, and cost-effectiveness of NGS, making it more accessible to a wider range of applications. The increasing adoption of NGS in diagnostics, drug discovery, personalized medicine, and other sectors is expanding the market opportunities for players across the value chain. Furthermore, the growing investments in genomics research, both from public and private entities, are fueling the development of new applications and driving market growth.

Segment-wise analysis of the North America NGS market reveals a diverse array of product and service offerings catering to different needs within the industry. Pre-sequencing products and services, NGS platforms, consumables, sequencing services, data analysis storage, and management solutions are all essential components of the NGS workflow. Each segment plays a crucial role in enabling researchers and clinicians to extract valuable insights from genomic data efficiently. By categorizing the market based on technology, it becomes clear that there are various sequencing methods available, each with its unique strengths and applications. From sequencing by synthesis to single-molecule real-time sequencing, researchers have a range of tools at their disposal to tackle different challenges in genomics.

The applications of NGS in North America span across multiple sectors, including diagnostics, drug discovery, biomarker discovery, personalized medicine, agriculture, animal research, and others. The versatility of NGS technology is reflected in its ability to address diverse needs, from identifying disease-causing mutations to optimizing crop yields through genomic selection. The wide range of end-users in the market, including academic research centers, pharmaceutical and biotechnology companies, hospitals, clinics, and others, underscores the widespread adoption of NGS across different sectors.

Key players in the North America NGS market, such as Illumina, Thermo Fisher Scientific, Qiagen, and Roche, among others, are actively engaged in strategic initiatives**Market Players:**
- Agilent Technologies, Inc. (U.S.)
- Thermo Fisher Scientific, Inc. (U.S.)
- QIAGEN (Netherlands)
- Illumina, Inc. (U.S.)
- Bio-Rad Laboratories, Inc. (U.S.)
- BGI (A subsidiary of BGI Group) (China)
- Oxford Nanopore Technologies plc (U.K.)
- Pacific Biosciences of California, Inc. (U.S.)
- 10x Genomics, Inc. (U.S.)
- PerkinElmer, Inc. (U.S.)
- Genewiz (U.S.)
- Partek Incorporated (U.S.)
- Becton, Dickinson and Company (BD) (U.S.)
- Genomic Health, Inc. (U.S.)
- Guardant Health, Inc. (U.S.)
- Personalis, Inc. (U.S.)

The North America Next Generation Sequencing (NGS) market is positioned for significant growth by 2030 due to various key factors. Advancements in sequencing technologies such as sequencing by synthesis, ion semiconductor sequencing, and single-molecule real-time sequencing are enhancing the speed, accuracy, and cost-effectiveness of NGS applications. This progress is making NGS more widely accessible in sectors like diagnostics, drug discovery, personalized medicine, and agriculture. The increasing investments in genomics research are also propelling market expansion, generating new opportunities for market players to grow and innovate.

The

Explore Further Details about This Research North America Next Generation Sequencing (NGS) Market Report:
https://www.databridgemarketresearch.com/reports/north-america-next-generation-sequencing-ngs-market

Key Benefits for Industry Participants and Stakeholders: –

Industry drivers, trends, restraints, and opportunities are covered in the study.
Neutral perspective on the North America Next Generation Sequencing (NGS) Market scenario
Recent industry growth and new developments
Competitive landscape and strategies of key companies
The Historical, current, and estimated North America Next Generation Sequencing (NGS) Market size in terms of value and size
In-depth, comprehensive analysis and forecasting of the North America Next Generation Sequencing (NGS) Market

Detailed TOC of North America Next Generation Sequencing (NGS) Market Insights and Forecast to 2030

Part 01: Executive Summary

Part 02: Scope Of The Report

Part 03: Research Methodology

Part 04: North America Next Generation Sequencing (NGS) Market Landscape

Part 05: Pipeline Analysis

Part 06: North America Next Generation Sequencing (NGS) Market Sizing

Part 07: Five Forces Analysis

Part 08: North America Next Generation Sequencing (NGS) Market Segmentation

Part 09: Customer Landscape

Part 10: Regional Landscape

Part 11: Decision Framework

Part 12: Drivers And Challenges

Part 13: North America Next Generation Sequencing (NGS) Market Trends

Part 14: Vendor Landscape

Part 15: Vendor Analysis

Part 16: Appendix

Browse More Reports:

Data Bridge Market Research:

Today's trends are a great way to predict future events!

Data Bridge Market Research is a market research and consulting company that stands out for its innovative and distinctive approach, as well as its unmatched resilience and integrated methods. We are dedicated to identifying the best market opportunities, and providing insightful information that will help your business thrive in the marketplace. Data Bridge offers tailored solutions to complex business challenges. This facilitates a smooth decision-making process. Data Bridge was founded in Pune in 2015. It is the product of deep wisdom and experience.

Contact Us:

Data Bridge Market Research

US: +1 614 591 3140

UK: +44 845 154 9652

APAC: +653 1251 978

Email:- corporatesales@databridgemarketresearch.com